Degnan Chris — SEC insider filings
SEC reporting owner CIK 1741968. 8 insider filings on record with FilingPulse; latest filed 2026-10-09.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2021-01-28 to 2026-10-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 10,000 shares, $19,593 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 4,405 shares, $117,912 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 2,202 shares @ $36.69 ($80,791) in UroGen Pharma Ltd., filed 2026-10-09.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | Chief Financial Officer | 4 | — | 2 legs · 4,405 sh · $117,912 | 7 |
| Galera Therapeutics, Inc. (GRTX) | Chief Financial Officer | 4 | 1 leg · 10,000 sh · $19,593 | — | 3 |
Insider filings — Degnan Chris
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-09 | 4 | UroGen Pharma Ltd. (URGN) | Option exercise (M): 4,483 · Sale (S): 2,202 @ $36.69 · Option exercise (M): 4,483 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | UroGen Pharma Ltd. (URGN) | Grant/award (A): 32,609 (derivative) @ $0 | EDGAR |
| 2025-10-09 | 4 | UroGen Pharma Ltd. (URGN) | Option exercise (M): 4,483 · Sale (S): 2,203 @ $16.85 · Option exercise (M): 4,483 (derivative) @ $0 | EDGAR |
| 2024-10-09 | 4 | UroGen Pharma Ltd. (URGN) | Grant/award (A): 13,450 (derivative) @ $0 · Grant/award (A): 74,142 (derivative) @ $0 | EDGAR |
| 2023-03-14 | 4 | Galera Therapeutics, Inc. (GRTX) | Purchase (P): 10,000 @ $1.96 | EDGAR |
| 2023-02-28 | 4 | Galera Therapeutics, Inc. (GRTX) | Grant/award (A): 185,000 (derivative) @ $0 | EDGAR |
| 2022-03-02 | 4 | Galera Therapeutics, Inc. (GRTX) | Grant/award (A): 135,000 (derivative) @ $0 | EDGAR |
| 2021-01-28 | 4 | Galera Therapeutics, Inc. (GRTX) | Grant/award (A): 82,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-01-21 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1741968 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs